Skip to content
2000
Volume 9, Issue 3
  • ISSN: 1871-5230
  • E-ISSN: 1875-614X

Abstract

Vasogenic edema resultant from malignant brain and spine tumors can impart neurological disability and life threatening compression of the central nervous system. Clinical management of edema requires a working understanding of the blood brain barrier, blood cerebrospinal fluid barrier, and the major mechanisms that tumors utilize to disrupt the normal function of these barriers. Corticosteroids and anti-angiogenic agents allay vasogenic edema and serve as fundamental treatment strategies for brain and spine tumor patients. This section reviews relevant microscopic anatomy, pathologic processes and inflammatory mediators important in the production of vasogenic cerebrospinal edema, and the rationale behind management strategies of edema in this patient population.

Loading

Article metrics loading...

/content/journals/aiaamc/10.2174/1871523011009030221
2010-09-01
2025-09-26
Loading full text...

Full text loading...

/content/journals/aiaamc/10.2174/1871523011009030221
Loading

  • Article Type:
    Research Article
Keyword(s): anti-inflammatory agents; Blood brain barrier; brain tumor; cerebrospinal fluid; edema
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test